T-Guard as Treatment for Steroid Refractory Acute GVHD
Condition: Steroid-Refractory Acute Graft Versus Host Disease Intervention: Drug: T-Guard Sponsors: Xenikos; National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI); National Marrow Donor Program Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Cardiology | Clinical Trials | Heart | Heart Transplant | Lung Transplant | Research | Transplant Surgery | Transplants